Send us a text

Why do so many digital pathology tools stall before they ever reach patients?

In this USCAP 2025 special sponsored by Muse Microscopy, I talk with Esther Abels, founder of SolarisRTC, regulatory strategist, and the force behind the first FDA-cleared whole slide imaging system.

We break down what startups and established companies must do from day one to succeedbin getting their devices through the FDA. Hint: regulatory strategy isn’t a final step—it’s your starting line.

🧠 What You’ll Learn:

• [00:01:00] Why regulatory planning must start at inception
• [00:03:00] How Esther helped Philips get the first scanner FDA cleared
• [00:05:00] Clinical study design, documentation, and risk strategy
• [00:08:00] Timeline expectations for clearance and review
• [00:10:00] The role of consultants vs. internal regulatory teams
• [00:13:00] Using meta-analysis, synthetic data, and publications
• [00:15:00] How the DPA is driving system decoupling & AI regulatory clarity
  
  

🎧 Tune in to learn how to build compliance into innovation—from tissue imaging to AI-powered diagnostics.

#DigitalPathology #RegulatoryStrategy #FDAApproval #ClinicalInnovation #PathologyTools #MUSEmiscroscopy #sponsored #USCAP2025

Support the show

Become a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!